https://scholars.lib.ntu.edu.tw/handle/123456789/550254
標題: | Hepatitis C virus load during pregnancy and puerperium | 作者: | HO-HSIUNG LIN JIA-HORNG KAO |
公開日期: | 2000 | 卷: | 107 | 期: | 12 | 起(迄)頁: | 1503-1506 | 來源出版物: | British Journal of Obstetrics and Gynaecology | 摘要: | Objective: To assess whether pregnancy and delivery influence serum levels of hepatitis C virus (HCV) in carrier mothers. Design: A prospective study. Setting: University department of obstetrics and gynaecology. Participants: Ten pregnant HCV carriers (group A) and 8 nonpregnant HCV carriers (group B). Methods: Serum samples were collected for group A at first and third trimesters, delivery, postpartum 1, 3, 6, 9 and 12 months, and at every three months for 1 year for group B. Main outcome measures: Each serum sample was tested for serum alanine aminotransferase (ALT), anti-HCV titre and HCV-cDNA concentration by a competitive polymerase chain reaction (PCR) with a sensitivity of 250 copies/mL serum. Results: In group A, the HCV levels remained unremarkably changed during pregnancy and delivery. However, all women had decreased HCV levels 1 and 3 months after delivery. Two women had undetectable serum HCV level postpartum and thereafter. Serum ALT values in 3 women were sporadically elevated, but did not correlate with decreased serum HCV levels. Anti-HCV titres remained unchanged during the study period. In two women from group B, the serum HCV levels were undetectable during follow up. Other 6 women showed fluctuations in the serum HCV levels but all were above 250 copies/mL. Serum ALT values were normal and anti-HCV titres remained stationary in all 8 nonpregnant carriers. Conclusion: Serum HCV levels are decreased 1 and 3 months after delivery. This fact might suggest that puerperium is an optimal time for antiviral therapy in HCV carrier mothers. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034519278&doi=10.1111%2fj.1471-0528.2000.tb11675.x&partnerID=40&md5=28e82a471c4293b8051413eb8f339369 https://scholars.lib.ntu.edu.tw/handle/123456789/550254 |
ISSN: | 0306-5456 | DOI: | 10.1111/j.1471-0528.2000.tb11675.x | SDG/關鍵字: | alanine aminotransferase; antivirus agent; complementary DNA; hepatitis C antibody; adult; alanine aminotransferase blood level; antibody detection; antimicrobial therapy; article; clinical article; controlled study; delivery; disease carrier; female; follow up; hepatitis C; Hepatitis C virus; human; polymerase chain reaction; pregnancy complication; priority journal; puerperal disorder; third trimester pregnancy; validation process; viremia; virus load; Adult; Alanine Transaminase; Carrier State; DNA, Complementary; DNA, Viral; Female; Follow-Up Studies; Hepacivirus; Hepatitis C Antibodies; Humans; Polymerase Chain Reaction; Pregnancy; Prospective Studies; Puerperal Disorders; Viral Load |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。